<DOC>
	<DOCNO>NCT02333331</DOCNO>
	<brief_summary>The purpose study determine efficacy repeat dose multiple dose level bimagrumab patient physical function , skeletal muscle mass strength old adult sarcopenia . In addition , study generate data safety , tolerability , pharmacokinetics bimagrumab old adult sarcopenia .</brief_summary>
	<brief_title>Dose Range Finding Study Bimagrumab Sarcopenia</brief_title>
	<detailed_description />
	<mesh_term>Sarcopenia</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Antibodies , Blocking</mesh_term>
	<criteria>Low muscle mass confirm DXA ; Low gait speed ; SPPB score less equal 9 ; Weigh least 35 kg ; Adequate dietary intake ; A low limb fracture past 6 month impairment disease severely affect gait ( e.g . stroke hemiparesis , myasthenia gravis , Parkinson 's disease , peripheral polyneuropathy , intermittent claudication advance peripheral vascular disease , spinal stenosis , severe osteoarthritis knee hip ineffective pain management ) ; Requires regular assistance another person general activity daily live ( e.g . bathing , dress , toileting ) . Intraocular surgery laser procedure refractive correction within 6 month prior screen ; Any underlying muscle disease include active myopathy muscular dytrophy ; Confirmed diagnosis heart failure classify New York Heart Association Class III IV ( e.g . dilate cardiomyopathy ) ; Type I diabetes uncontrolled Type 2 diabetes ; Chronic kidney disease [ estimate glomerular filtration rate ( GFR ) &lt; 30 mL/min ] ; History confirm chronic obstructive pulmonary disease severity grade &gt; 2 Medical Research Council Dyspnea Scale ; Confirmed rheumatoid arthritis systemic autoimmune disease require immunosuppressive therapy corticosteroid &gt; 10 mg/d prednisone equivalent ; Known history presence severe active acute chronic liver disease ( e.g. , cirrhosis ) ; Myocardial infarction , coronary artery bypass graft surgery , percutaneous coronary intervention ( e.g . angioplasty stent placement ) , deep vein thrombosis/pulmonary embolism within 12 week screen ; Active cancer ( i.e. , current treatment ) , cancer require treatment last 5 year exclude nonmelanoma skin cancer cancer excellent prognosis ( e.g. , early stage prostate breast cancer , carcinoma situ uterine cervix ) ; Any chronic active infection ( e.g. , HIV , Hepatitis B C , tuberculosis , etc ) .</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Sarcopenia , muscle wasting , elderly , strength , physical function , muscle , gait speed</keyword>
</DOC>